China Chemotherapy-Induced Nausea and Vomiting Drugs Market Research Report 2018

Publisher Name :
Date: 13-Apr-2018
No. of pages: 96
Inquire Before Buying

The global Chemotherapy-Induced Nausea and Vomiting Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Chemotherapy-Induced Nausea and Vomiting Drugs development status and future trend in China, focuses on top players in China, also splits Chemotherapy-Induced Nausea and Vomiting Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

- Merck & Co., Inc.

- GlaxoSmithKline plc

- Tesaro, Inc.

- Helsinn Group

- F. Hoffmann-La Roche Ltd.

- Heron Therapeutics, Inc.

- Dr. Reddy's Laboratories Ltd.

- Acacia Pharma

- Sun Pharmaceutical Industry Ltd.

- Otsuka Holdings Co., Ltd.

Geographically, this report splits the China market into six regions,

- South China

- East China

- Southwest China

- Northeast China

- North China

- Central China

- Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

- Existing Drugs

- Akynzeo (Netupitant-Palonosetron FDC)

- Aloxi (Palonosetron)

- Emend (Aprepitant)

- Kytril Generic (Granisetron)

- Zofran Generic (Ondansetron)

- Pipeline Drugs

- SUSTOL (Granisetron Injection extended release)

- Rolapitant

On the basis of the end users/application, this report covers

- Serotonin Receptor Antagonists

- NK1 Receptor Antagonists

If you have any special requirements, please let us know and we will offer you the report as you want.

China Chemotherapy-Induced Nausea and Vomiting Drugs Market Research Report 2018

Table of Contents
China Chemotherapy-Induced Nausea and Vomiting Drugs Market Research Report 2018
1 Chemotherapy-Induced Nausea and Vomiting Drugs Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Classification of Chemotherapy-Induced Nausea and Vomiting Drugs by Product Category
1.2.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Comparison by Type (2013-2025)
1.2.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Market Share by Type in 2017
1.2.3 Existing Drugs
1.2.4 Akynzeo (Netupitant-Palonosetron FDC)
1.2.5 Aloxi (Palonosetron)
1.2.6 Emend (Aprepitant)
1.2.7 Kytril Generic (Granisetron)
1.2.8 Zofran Generic (Ondansetron)
1.2.9 Pipeline Drugs
1.2.10 SUSTOL (Granisetron Injection extended release)
1.2.11 Rolapitant
1.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Market by Application/End Users
1.3.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Market Share Comparison by Applications (2013-2025)
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 China Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region
1.4.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Million USD) Comparison by Region (2013-2025)
1.4.2 South China Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
1.4.3 East China Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
1.4.4 Southwest China Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
1.4.5 Northeast China Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
1.4.6 North China Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
1.4.7 Central China Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Chemotherapy-Induced Nausea and Vomiting Drugs (2013-2025)
1.5.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
1.5.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Competition by Players/Manufacturers
2.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Competitive Situation and Trends
2.4.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration Rate
2.4.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base Distribution, Sales Area, Product Types
3 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue by Region (2013-2018)
3.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Regions (2013-2018)
4 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Type (2013-2018)
4.4 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (%) by Type (2013-2018)
5 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2013-2018)
5.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 China Chemotherapy-Induced Nausea and Vomiting Drugs Players/Suppliers Profiles and Sales Data
6.1 Merck & Co., Inc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline plc
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.2.4 Main Business/Business Overview
6.3 Tesaro, Inc.
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.3.4 Main Business/Business Overview
6.4 Helsinn Group
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.4.4 Main Business/Business Overview
6.5 F. Hoffmann-La Roche Ltd.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.5.4 Main Business/Business Overview
6.6 Heron Therapeutics, Inc.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.6.4 Main Business/Business Overview
6.7 Dr. Reddy's Laboratories Ltd.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.7.4 Main Business/Business Overview
6.8 Acacia Pharma
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.8.4 Main Business/Business Overview
6.9 Sun Pharmaceutical Industry Ltd.
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.9.4 Main Business/Business Overview
6.10 Otsuka Holdings Co., Ltd.
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.10.4 Main Business/Business Overview
7 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Cost Analysis
7.1 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Chemotherapy-Induced Nausea and Vomiting Drugs Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Sales and Revenue) Forecast (2018-2025)
11.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Type (2018-2025)
11.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Application (2018-2025)
11.4 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2013-2025)
Figure Product Picture of Chemotherapy-Induced Nausea and Vomiting Drugs
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Types in 2017
Figure Existing Drugs Product Picture
Figure Akynzeo (Netupitant-Palonosetron FDC) Product Picture
Figure Aloxi (Palonosetron) Product Picture
Figure Emend (Aprepitant) Product Picture
Figure Kytril Generic (Granisetron) Product Picture
Figure Zofran Generic (Ondansetron) Product Picture
Figure Pipeline Drugs Product Picture
Figure SUSTOL (Granisetron Injection extended release) Product Picture
Figure Rolapitant Product Picture
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Chemotherapy-Induced Nausea and Vomiting Drugs by Application in 2017
Figure Serotonin Receptor Antagonists Examples
Table Key Downstream Customer in Serotonin Receptor Antagonists
Figure NK1 Receptor Antagonists Examples
Table Key Downstream Customer in NK1 Receptor Antagonists
Figure South China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales of Key Players/Manufacturers (2013-2018)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share (%) by Players/Manufacturers
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Players/Manufacturers (2013-2018)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) by Players/Manufacturers
Table China Market Chemotherapy-Induced Nausea and Vomiting Drugs Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Chemotherapy-Induced Nausea and Vomiting Drugs Average Price of Key Players/Manufacturers in 2017
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Market Share of Top 3 Players/Manufacturers
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Category
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Regions (2013-2018)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share (%) by Regions (2013-2018)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share (%) by Regions (2013-2018)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) by Regions in 2017
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) by Regions in 2017
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Regions (2013-2018)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2013-2018)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share (%) by Type (2013-2018)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share (%) by Type (2013-2018)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) by Type in 2017
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2013-2018)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type in 2017
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Types (2013-2018)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (%) by Type (2013-2018)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Applications (2013-2018)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) by Applications (2013-2018)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) by Application (2013-2018)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) by Application in 2017
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (%) by Application (2013-2018)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (%) by Application (2013-2018)
Table Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) in China (2013-2018)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) in China (2013-2018)
Table GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) in China (2013-2018)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) in China (2013-2018)
Table Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) in China (2013-2018)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) in China (2013-2018)
Table Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) in China (2013-2018)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) in China (2013-2018)
Table F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) in China (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) in China (2013-2018)
Table Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) in China (2013-2018)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) in China (2013-2018)
Table Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) in China (2013-2018)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) in China (2013-2018)
Table Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) in China (2013-2018)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) in China (2013-2018)
Table Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) in China (2013-2018)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) in China (2013-2018)
Table Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Basic Information List
Table Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share (%) in China (2013-2018)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
Table Raw Materials Sources of Chemotherapy-Induced Nausea and Vomiting Drugs Major Players/Manufacturers in 2017
Table Major Buyers of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Distributors/Traders List
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share Forecast by Type in 2025
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share Forecast by Application in 2025
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Regions (2018-2025)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Urinary Incontinence - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 86
    Urinary Incontinence - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakag......
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 130
    Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Acute kidney failure occurs when kidneys suddenly become unable to filter waste p......
  • Nocturia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 33
    Nocturia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H2 2018, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of ......
  • Secondary Hyperparathyroidism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Secondary Hyperparathyroidism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism - Pipeline Review, H2 2018, provides an overview of the Secondary Hyperparathyroidism (Hormonal Disorders) pipeline landscape. Secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyroid hormone (PTH) because calcium levels are too low. ......
  • 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 32
    72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018 Summary 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) pipeline Target constitutes close to 7 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the ......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs